Prof John Camm
Professor of Clinical Cardiology
St George’s University of London

John Camm is Professor of Clinical Cardiology at St George’s, University of London, UK, and Professor of Cardiology at Imperial College, London. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, and risk stratification in post-myocardial infarction, heart failure and cardiomyopathy patients.

Professor Camm graduated from Guy's Hospital, London and pursued a career in cardiology at St Bartholomew's Hospital, London, before moving to St George’s in 1986. He was elected Chairman of Medicine in October 1990. He was Chairman of the Division of Cardiological Sciences from 1986 until 2010. He is now Professor Clinical Cardiology at both St George’s University of London and Imperial College, London.

Professor Camm is a Fellow of the Academy of Medical Sciences (London) the Royal College of Physicians (London, Edinburgh and Glasgow), the American College of Cardiology, the American Heart Association, the European Heart Rhythm Association, and the European Society of Cardiology (ESC).

He is President of the European Heart Rhythm Association, Arrhythmia Alliance, and Founder of the Atrial Fibrillation Association. Professor Camm is also a Trustee of the Atrial Fibrillation Association, the Drug Safety Research Unit and is a non-executive director of Richmond Pharmacology Limited.

He is a past trustee of the American College of Cardiology, and the British Cardiovascular Society. He is Past President of the British Cardiovascular Society, the British Pacing and Electrophysiology Group, the British Cardiac Physiologists Society, the European Working Group on Cardiac Electrophysiology and the North American Society of Pacing and Electrophysiology.

Professor Camm is past Editor in Chief of EP-Europace, current Editor-in-Chief of Clinical Cardiology and European Heart Journal Case Repots, Editor of the European Heart Journal, and editorial board member of a further 15 journals.

He is also Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine, Electrophysiology of the Heart, Clinical Cardiology and Evidence Based Medicine. He has written or edited more than 40 books, predominantly in the field of cardiac arrhythmology. He has authored or co-authored almost 1,300 peer reviewed papers, more than 500 book chapters, and in excess of 2,500 accepted abstracts. He has delivered more than 500 international lectures. H Index is 109.

Professor Camm has been involved in the production of numerous guidelines, including the ESC guidelines for the management of atrial fibrillation and the NICE guidelines for the treatment of unstable angina and non-ST elevation ACS. Professor Camm was awarded the ESC Gold Medal in 2005 and the British Cardiovascular Society Mackenzie Medal in 2008.

Dr Subodh Verma
Cardiac Surgeon, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON
Scientist, Keenan Research Centre for Biomedical Science and Li Ka Shing
Knowledge Institute of Unity Health Toronto, Toronto, ON
Professor of Surgery and Pharmacology & Toxicology, University of Toronto,
Toronto, ON
Canada Research Chair in Cardiovascular Surgery

Dr Subodh Verma is an internationally renowned cardiac surgeon-scientist and Professor at the University of Toronto. He is the Canada Research Chair in Cardiovascular Surgery and a past recipient of the Howard Morgan Award for Distinguished Achievements in Cardiovascular Research and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He is an appointee of the American Association of Thoracic Surgeons (AATS) and a member of the College of New Scholars, Artists and Scientists, Royal Society of Canada. Dr Verma has an h-index of 67, with nearly 18,000 citations to 385 publications.

Dr Verma has co-authored two state-of-the-art NEJM reviews on mitral valve repair and bicuspidaortopathy. A meta-analysis led by him helped shape the recommendations of the American College of Cardiology and the Canadian Cardiovascular Society (CCS) for best revascularization choice in individuals with diabetes. He continues to be an active contributor to several CCS guidelines and co-authored the 2018 Diabetes Canada guidelines and 2018 AATS consensus guidelines on bicuspid aortic valve-related aortopathy. Dr Verma has served on the American Heart Association Council on Cardiovascular Surgery and Anesthesia since 2008.

Dr Verma has leadership roles on all 5 ongoing global heart failure trials in diabetes – Dapa-HF, DELIVER, EMPEROR-Preserved, EMPEROR-Reduced and SOLOIST-WHF – as well as the SELECT (semaglutide) and CLEAR SYNERGY (OASIS 9) trials. Locally, he spearheads the CardioLink platform that focusses on questions at the crossroads of cardiovascular surgery, perioperative medicine, cardiology, and diabetes.

Dr Verma oversees a dynamic pre-clinical and translational research team that leverages preclinical disease models and clinical trial-derived data to identify novel mediators of cardiovascular and cardiometabolic disease as well as answer timely and relevant healthcare questions. This research has yielded 2 United States patents and is currently supported by the Canadian Institutes of Health Research (CIHR) and HSF.
 

Dr Michael Valentine
Immediate Past-President
American College of Cardiology

C. Michael Valentine, MD, FACC, is the immediate Past-President of the ACC and an interventional cardiologist at Centra Health in Lynchburg, VA. He is a graduate of the University of Georgia, where he was named the outstanding senior, as well as the University of Virginia School of Medicine. He completed his medicine and cardiology training at Emory University in Atlanta, GA.

He first became involved with the ACC in 1993 and has worked his way up through the leadership ranks, including previously serving on the Advocacy Committee, as Virginia Chapter governor, as Board of Governors chair, treasurer and on the Board of Trustees.

Dr Abel Pavia
Consultant Cardiologist
Hospital General de Mexico

Professor Abel Pavia is currently Chief of the Interventional Cardiology Department at Centro Hospitalario Beuvo Sanatoria Durango, Mexico, and co-ordinator of the Coronary Heart Disease Clinic in the Cardiology Department of Hospital General de Mexico. Professor Pavia attained his medical degree at Universidad Nacional Autónoma de México, and went on to conduct his cardiology residencies at Hospital Español de México and Cleveland Clinic Foundation. He also completed his interventional training in Intracoronary Stent Implantation at Fundación Clínica Shaio in Colombio.

During his career, Prof Pavia has held distinguished positions in professional societies such as the Mexico Society for Atherosclerosis Prevention (President, 2003-2005), and most recently, as President of the Atherosclerosis Committee of Cardiology (2015-2017). With numerous publications and book chapters under his belt, he has also led and participated in several landmark trials such as the CRUICIAL, SIGNIFY, PARADIGM trials.

Dr Robert Nussbaum
Chief Medical Officer
Invitae

Robert L. Nussbaum, is the Chief Medical Officer of Invitae, a genetic information and diagnostic company. He is board certified in internal medicine, clinical genetics and clinical molecular genetics, and is a Fellow of the American College of Physicians and the American College of Medical Genetics and Genomics. From 2006-2015, he was the Holly Smith Professor of Medicine at UCSF, Chief of the Division of Genomic Medicine and Medical Director of both the Cancer Risk Program and the UCSF Program in Cardiovascular Genetics.

He trained in Medicine at Harvard Medical School, internal Medicine at Washington University/Barnes Hospital in St. Louis, and received Clinical Genetics training at Baylor College of Medicine.

He is the co-author of nearly 250 peer-reviewed publications in basic human genetics and clinical medical genetics as well as numerous commentaries, editorials, and textbook chapters. He was elected to the American Society for Clinical Investigation, the Association of American Physicians, the National Academy of Medicine and the American Academy of Arts and Sciences. Dr. Nussbaum served as a member of the Board of Directors and President of the American Society of Human Genetics, on the Board of Directors of the American Board of Medical Genetics and Genomics, was a founding fellow and member of the Board of Directors of the American College of Medical Genetics and Genomics, and was elected a fellow of the American College of Physicians. He is the recipient of many awards for research and teaching including the Klaus Joachim Zülch-Prize for Neurological Research from the Gertrud Reemtsma Foundation/Max Planck Society (2011), the Van Andel Prize for Achievement in Parkinson Disease Research (2015), an Education Award from the American Society of Human Genetics (Co-awardee with Drs. Huntington Willard and Roderick McInnes) (2015) and the Donald Calne honorary lectureship, Parkinson Canada (2016).

Dr Jeroen Hendriks
Derek Frewin Lectureship
Centre for Heart Rhythm Disorders, University of Adelaide and the Royal Adelaide Hospital

Dr Jeroen Hendriks, RN, PhD, FESC, FSCANZ, holds the Derek Frewin Lectureship at the Centre for Heart Rhythm Disorders, University of Adelaide and the Royal Adelaide Hospital. His program of research focusses on integrated care management in atrial fibrillation and related cardiovascular disease. This redesign practice model follows a patient-centred approach and incorporating allied health professionals in the management process. He holds a Future Leader Fellowship from the Australian Heart Foundation. Within the Centre for Heart Rhythm Disorders Dr. Hendriks is responsible for developing the Academic Nursing Program on Atrial Fibrillation.

Dr Hendiks undertook his PhD at the Maastricht University Medical Centre in Maastricht, the Netherlands. His PhD work demonstrated the important role of Integrated Care Management in terms of dedicated atrial fibrillation clinics to improve the outcomes in patients with atrial fibrillation. Importantly it demonstrated a significant reduction in cardiovascular hospitalisation and mortality.

He served on the Task Force Writing Committee to develop the 2016 European Society of Cardiology Guidelines for the management of Atrial Fibrillation, and on the Writing Committee to develop the 2018 Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation.

He is Editorial Board member of the European Journal of Cardiovascular Nursing, The International Journal of Care Coordination, and ICT&Health International.

Dr Hendriks is the President of the Australian Cardiovascular Health and Rehabilitation Association (ACRA SA/NT) and is Board Director and Treasurer of the Australasian Cardiovascular Nursing College (ACNC). Internationally, he is the Past-President of the Dutch Society for Cardiovascular Nurses (NVHVV) and the Past Communication Officer of the Council for Cardiovascular Nursing and Allied Professions (CCNAP) within the European Society of Cardiology.

Dr Brian A.Ference
Cardiologist & Genetic Epidemiologist
University of Cambridge, UK

Brian is a cardiologist and genetic epidemiologist who was educated and trained at Harvard, Yale, Oxford and Cambridge Universities.

He graduated from Yale Medical School, and trained as a clinical investigator resident in Internal Medicine and as a special student in clinical epidemiology and genetic epidemiology as part of the Robert Wood Johnson Clinical Scholars Program at Yale. He then trained in cardiology and interventional cardiology at Harvard Medical School. While at Harvard, he also completed the Program in Clinical Effectiveness at Harvard School of Public Health, and was an NHLBI Cardiovascular (Genetic) Epidemiology Fellow at the Brigham and Women’s Hospital and Harvard Medical School. He then earned a business degree from the University of Cambridge, and a degree in evidence-based medicine from the University of Oxford.

He is currently Professor / Director of Research in Translational Therapeutics, and Head of the Centre for Naturally Randomized Trials at the University of Cambridge, UK; and Benjamin Meaker Visiting Professor in Cardiovascular Medicine in the Institute for Advanced Studies at the University of Bristol, UK. Prior to that he was Clinical Chief of Cardiology and Director of the Cardiovascular Genomic Research Centre at Wayne State University School of Medicine in Detroit, and the Chief Medical and Scientific Officer of the US-Sino Collaboration working on the Chinese Precision Medicine Initiative in Beijing. His research focuses on using Mendelian randomization to design ‘naturally randomized trials’ to generate naturally randomized evidence that can be used to improve the drug discovery and development process; inform the optimal design of randomized trials; fill evidence gaps when a randomized trial is not possible or practical; and define the practice of precision cardiovascular medicine.

Prof Peter Collins
Professor of Clinical Cardiology
National Heart and Lung Institute, Imperial College, London

Peter Collins is Professor of Clinical Cardiology, National Heart and Lung Institute, Imperial College London, and Honorary Consultant Cardiologist at the Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust.

Professor Collins was an undergraduate at Caius College, Cambridge University before moving to St Thomas’ Hospital Medical School. He conducted his research for an MD degree at the University Hospital of Wales, Cardiff, receiving his MD degree from the University of Cambridge, and won the University’s Sir Walter Langdon-Brown prize for the thesis. He was appointed Consultant Cardiologist in 1989 and appointed Professor of Clinical Cardiology at Imperial College in 2001. He is responsible for the education and training of specialist cardiology trainees at the Royal Brompton and Harefield NHS Foundation Trust and runs the undergraduate cardiology medical course for final year medical students for Imperial College at the Royal Brompton campus. He chairs the Final Year Cardiology course committee at Imperial College and the Education and Training board at the Royal Brompton and Harefield NHS Foundation Trust.

Professor Collins is a Fellow of the Royal College of Physicians of London, the American College of Cardiology, the European Society of Cardiology. He is a member of the British Cardiac Society and the prestigious Association of Physicians of Great Britain and Ireland. He is and has been a member and board member of several renowned societies and committees such as the International Menopause Society, British Menopause Society and European Society of Cardiology. He is currently the Chairman of the newly formed Task Force on Gender of the European Society of Cardiology.

His principle clinical interests are in cardiovascular disease and in particular cardiovascular disease in women, coronary heart disease, hypertension hyperlipidaemia, insulin resistance and diabetes. He has been instrumental in setting up and running the ‘Women’s Heart Clinic’ at the Royal Brompton Hospital, one of the first of its kind in the UK.

Professor Collins’ research interests include coronary flow control mechanisms, both in normal and disease states including ischemic heart disease, hypertension and heart failure, and the role of the endothelium in cardiovascular physiology and pathophysiology. His research on the endothelium led to work investigating the vascular effects of a number of different hormones including, oestrogens, progestins, androgens, SERMS and phytoestrogens, to identify the mechanisms of action and effects of these hormones in the cardiovascular system. He has extensively researched the rare but complex condition known as cardiac Syndrome X, a condition of troublesome chest pain in the absence of coronary heart disease, and has established a number of new treatment modalities for this difficult-to-manage syndrome.

Professor Collins has supervised numerous research students, many of whom are now consultant cardiologists, and has published extensively in many international peer-reviewed journals. He is the co-Editor of ‘Women and Heart Disease’, and recently has been responsible for the publication of a cardiovascular risk factor guide for menopause physicians in an attempt to improve the awareness, and aid with the management, of cardiovascular risk factors in menopausal women.

Prof Jeroen Bax
Immediate Past-President
European Society of Cardiology

Prof Jeroen J. Bax, FESC (Leiden, Netherlands)
ESC Immediate Past-President (2018 – 2020), Jeroen Bax is Director of non-invasive imaging and Director of the echo-lab at the Leiden University Medical Center. His main interests include clinical cardiology, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these clinical fields. Professor Bax has authored numerous papers and holds several positions in national and international scientific organizations, as well as serving on the editorial boards of many different journals.

DR ALBERT HANS BAUTISTA
Consultant Cardiologist and Hypertension Specialist
Clinical Head, Cardiac and Peripheral Vascular Diagnostic Center,
The Medical City Hospital

Our speaker graduated from the University of Santo Tomas Faculty of Medicine and Surgery. He took his post-graduate internship and his specialty training in Internal Medicine at The Medical City Hospital. He then took his sub-specialty fellowship training in Adult Cardiology at the Philippine General Hospital Department of Medicine Section of Adult Cardiology, followed by his fellowship training in Clinical Research in Adult Cardiology. He then pursued further training in Peripheral Vascular Diseases at the St. Luke's Heart Institute Noninvasive Vascular Laboratory at Quezon City and at the University of Washington Medical Center, Vascular Diagnostic Services in Seattle Washington, USA.

He also took further training in Stress Echocardiography at the Hahnemann University Hospital Cardiac Imaging Laboratory in Philadelphia USA. He subsequently took further training in Research & Epidemiology at the Erasmus Medical Center in Rotterdam, Netherlands.

He is a diplomate and fellow of the Philippine College of Physicians (PCP) and likewise a diplomate and fellow of the Philippine College of Cardiology. He is presently a consultant cardiologist and a hypertension specialist practicing at The Medical City Hospital, the Clinical Head of the Cardiac and Peripheral Vascular Diagnostic Center of The Medical City Hospital. He is a member of the Section of Cardiology Fellowship Training Program of The Medical City Hospital. He is also a member of the Council on Cardiopulmonary Resuscitation of the Philippine Heart Association, a BLS and ACLS trainor.

ANC Fiona Pereira

Ms Fiona Pereira is an Assistant Nurse Clinician at the Tan Tock Seng Hospital.

She will be speaking on the title “Let’s Cool Now!”.

Ms Angela Ng

Ms Angela Ng is a Senior Manager, Health Management Unit at the Changi General Hospital.

She will be speaking on the title “Heart Failure Telemonitoring Programme – The EHA Experience”.

Ms Nancy Yong

Ms Nancy Yong is a Senior Principal Pharmacist (Clinical) at the National University Hospital.

She will be speaking on the title “Perspective from A Clinical Pharmacist on National Collaborative Prescribing Program”.

Dr Goh Su-Yen

Dr Goh Su-Yen is a Head and Senior Consultant in Endocrinology at the Singapore General Hospital. She will be speaking on the title “Redefining T2DM Management”.

Adj Asst Prof Wong Cheok Keng Kelvin

Adj Asst Prof Kelvin Wong Cheok Keng is a consultant Cardiologist and Electrophysiologist at the Changi General Hospital and Visiting Consultant to National Heart Centre Singapore. His area of subspecialty is in Electrophysiology and Pacing.

He will be speaking on the title “Syncope”.

Ms Thng Shu Hui

Ms Thng Shu Hui is a Senior Pharmacist at the National Heart Centre Singapore.

She will be speaking on the title “Anticoagulation in Patients with Moderate Renal Impairment (NOACs) and Anticoagulation in Frail Patients (NOACs)”.

Ms Teo Wei Yin Germaine

Ms Germaine Teo is a Pharmacist at the National Heart Centre Singapore.

She will be speaking on the title “PCSK9 inhibitors-Everybody Go Get that Miracle LDL-buster!”.

Adj Assoc Prof Tan Swee Yaw

Adjunct Associate Professor Tan Swee Yaw is a Senior Consultant with the Department of Cardiology and the Director of Cardiovascular Rehabilitation and Preventive Cardiology at the National Heart Centre Singapore. His area of subspecialty is in Rehabilitation Medicine, Cardiac Magnetic Resonance Imaging.

He will be speaking on the title “Apple Heart Study”.

Adj Assoc Prof Tan Ru San

Adj Assoc Prof Tan Ru San is a Senior Consultant with the Department of Cardiology at the National Heart Centre Singapore. His area of subspecialty is in Non-invasive Cardiac Imaging.

He will be speaking on the title “IN (In-patient initiation of Entresto)”.

Dr Arthur Tan Teow Hin

Dr Arthur Tan is a Cardiologist at the Gleneagles Medical Centre in Singapore. He has been actively involved in Cardiology in Singapore for the past 2 decades. Dr Tan initiated the structured postgraduate training in Cardiology in the Ministry of Health, Singapore

He will be speaking on the title “Do's and Dont's For Prolonged DAPT Post ACS”.

Dr Phoon Kwong Yun Ian

Dr Ian Phoon is a Consultant and Family Physician at SingHealth Polyclinics
He will be speaking on the title “Palpitations”.

Dr Ong Sea Hing

Dr Ong Sea Hing is a Consultant Cardiologist and Physician at Baldev & Ong The Cardio Clinic. His area of subspecialty is in coronary artery angioplasty and stenting including complex coronary interventions. He is also trained in structural heart interventions. He will be speaking on the title “Managing Myocardial Ischemia-PCI and Beyond”.

Dr Ong Hean Yee

Dr Ong Hean Yee is a Cardiologist at the Mount Elizabeth Novena Hospital. He is also the current President of the Singapore Cardiac Society. He has special clinical and research interests in the areas of cardiac screening, lipidaemia, exercise testing, heart failure and advanced cardiac imaging.

He will be speaking on the titles “Challenges in Management of Hypertension and Management of the CV Continuum: Are there Gender Differences?”.

COL (Dr) Ng Yih Yng

COL (Dr) Ng Yih Yng is currently the Chief Medical Officer of the SCDF, in-charge of National Emergency Medical Services and holds concurrent appointments as the HomeTeam CMO of MHA, Deputy Director of the Unit for Prehospital Emergency and as a Visiting Consultant of the Hospital Services Division, MOH. Clinically, he practices Emergency Medicine as a Consultant at TTSH ED.

He will be speaking on the title “Improving First Responder Response Time”.

Ms Low Peik Ching

Ms Low Peik Ching is a Senior Pharmacist (Clinical) at the National University Hospital.

She will be speaking on the title “Entresto-Entrust for a Price?”.

Assoc Prof Low Fatt Hoe Adrian

Assoc Prof Adrian Low Fatt Hoe is a Senior Consultant Cardiologist at National University Heart Centre Singapore. His subspecialty is in Coronary and vascular interventions, Acute coronary syndromes, Invasive haemodynamics and Biomarkers and genetic determinants of cardiovascular diseases.

He will be speaking on the title “ECGs in Chest Pain”.

APN Regine Loo Yu Jen

Ms Regine Loo is an Advanced Practice Nurse (Med/Surg) at the National Heart Centre Singapore.

She will be speaking on the title “Nursing Experience in Transcutaneous Aortic Valve Implantation (TAVI) Service”.

Dr Lim Tien Siang Eric

Dr Eric Lim is a Consultant with the Department of Cardiology at the National Heart Centre Singapore. His area of subspecialty is in Electrophysiology and Pacing.

He will be speaking on the title “ECG Variants in Athletes”

Ms Elena Lee

Ms Elena Lee is a Principal Clinical Pharmacist at the Change General Hospital.

She will be speaking on the title “SGLT2 inhibitors-A Multi-faceted Potion to Behold”.

Dr Ivandito Kuntjoro

Dr Ivandito Kuntjoro is an Associate Consultant Cardiologist at the National University Heart Centre Singapore. His area of subspecialty is in adult congenital, pulmonary hypertension and structural heart disease.

He will be speaking on the title “TAVI Ready to Overtake Open AVR?”.

Assoc Prof Foo Sik Yin Roger

Assoc Prof Roger Foo Sik Yin is a Senior Consultant with the Department of Cardiology at the National University Heart Centre Singapore. He is also the Visiting Consultant for the National Heart Centre Singapore and Changi General Hospital. His subspecialty is in inherited cardiac conditions and cardiovascular epigenetics.

He will be speaking on the title “How You Might Make Genetic Testing Part of your Practice”.

Dr Fahim Jafary

Dr Fahim Jafary is a Senior Consultant at the Tan Tock Seng Hospital. He has clinical interest in Interventional Cardiology, Nuclear Cardiology and Cardiovascular CT.

He will be speaking on the title “Local Case Presentation: High Risk MI Patient”.

Dr Chua Chin Wee Dennis

Dr Dennis Chua is a Senior Pharmacist at the Ng Teng Fong General Hospital.

He will be speaking on the title “Anticoagulation in Patients with Moderate Renal Impairment (Warfarin) and Anticoagulation in Frail Patients (Warfarin)”.

Dr Chow Hui Jeremy

Dr Jeremy Chow Hui is a Consultant Cardiologist and Electrophysiologist at Gleneagles Hospital, Mount Elizabeth Hospital and Mount Elizabeth Novena Hospital. His area of subspecialty is in complex cardiac device management including cardiac resynchronization therapy, complex lead management and extractions, electrophysiology and ablations including atrial fibrillation and ventricular tachycardia.

He will be speaking on the title “OUT (Out-patient initiation of Entresto)”.

Adj Asst Prof Chia Yew Woon

Adj Asst Prof Chia Yew Woon is a Senior Consultant Cardiologist at the Tan Tock Seng Hospital. His clinical interests are in Cardiac Intensive Care, Extracorporeal Life Support and Critical Care Ultrasound.

He will be speaking on the title “Role of Therapeutic Hypothermia”.

Adj Asst Prof Chia Pow-Li

Adj Asst Prof Chia Pow-Li is a Deputy Head of Department, Senior Consultant at the Tan Tock Seng Hospital. His area of subspecialty is in Arrhythmia, Pacing and Electrophysiology Service.

He will be speaking on the title “Patients with AF and Renal Impairment: What do the Guidelines Say?”.

Assoc Prof Mark Chan Yan Yee

Associate Professor Mark Chan is a Senior Consultant at the National University Heart Centre Singapore. His subspecialty area is in interventional cardiology, platelet biology and pharmacology, metabolomics and risk stratification and Acute Coronary Syndromes.

He will be speaking on the title“Do Medically Managed ACS Patients Even Exist in Singapore”

Ms Breana Cham

Ms Breana Cham is a Senior Genetic Counsellor, Department of Paediatric Medicine at the KK Women’s and Children’s Hospital.

She will be speaking on the title “Genetic Counselling Considerations in Cardiac Conditions”.